EUROPEAN MEDICINES AGENCY UPDATE ON NON-SELECTIVE NSAIDS

The Agency's scientific committee, the Committee for Medicinal Products for Human Use (CHMP), concluded, at its meeting of 10-13 October 2005, that, on the basis of the data reviewed, there are no new safety concerns regarding cardiovascular and gastrointestinal safety and serious skin reactions with non-selective NSAIDs (non-steroidal anti-inflammatory drugs). NSAIDs remain important treatments for arthritis and other painful conditions. The review follows the Agency's findings in June 2005 on safety issues relating to selective NSAIDs (COX-2 inhibitors). The review was carried out at the request of the European Commission to look at non-selective NSAIDs to determine whether there were safety issues that required further action.

Medical News Today (http://www.medicalnewstoday.com/medicalnews.php?newsid=32160)